1887

Abstract

The switch from bradyzoites to tachyzoites is the fundamental pathogenic event that leads to encephalitis (TE) in patients with AIDS. Distinction between these stages is difficult, particularly when specific treatment has been started. A new approach consisting of a nested PCR (n-PCR) assay was performed on cerebrospinal fluid (CSF) specimens collected from AIDS patients with TE before or after antiparasitic therapy was initiated, to assess the efficacy of primer sets which amplify target sequences expressed on bradyzoites (SAG4 and MAG1), tachyzoites (SAG1) or both stages (B1) of . CSF specimens were obtained from 46 patients with AIDS, of whom 27 had TE (16 first episode, 11 relapse) and 19 had other AIDS-related brain lesions (AIDS-OBL) in the absence of TE. CSF specimens from 26 HIV-negative and immunocompetent patients were also checked. All samples were tested with different primer pairs targeting the B1, SAG-1, SAG-4 and MAG-1 genes. With B1, 75% of patients with first episodes of TE were positive, compared with 36.3% of those with relapse of TE and 5.2% of those with AIDS-OLB. The SAG1 gene yielded positive values in 28.7% and 45.4% of patients with first episodes of TE or relapse of TE, respectively, and in none of the controls. With the SAG4 and MAG1 genes, 72.7% of patients with relapse of TE were detected, compared with 25% of patients with first episodes of TE and 5.2% with AIDS-OLB. None of the HIV-negative subjects showed positive PCR reactions. These results demonstrate that specific primers for the genes SAG4, MAG1 and SAG1 may be useful in AIDS patients with relapse of TE, in whom the use of PCR targeting the B1 gene may fail to detect DNA, especially when prophylaxis or treatment has been started.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/0022-1317-51-10-879
2002-10-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/51/10/879.html?itemId=/content/journal/jmm/10.1099/0022-1317-51-10-879&mimeType=html&fmt=ahah

References

  1. Smith JE, McNeil G, Zhang YW, Dutton S, Biswas-Hughes G, Appleford P. Serological recognition of Toxoplasma gondii cyst antigens. In: Gross U (ed) Toxoplasma gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996:; 67–73.
  2. Partanen P, Turunen HJ, Paasivuo RAT, Leinikki PO. Immunoblot analysis of Toxoplasma gondii antigens by human immunogobulins G, M, and A antibodies at different stages of infection. J Clin Microbiol 1984;; 20: 133–135.
    [Google Scholar]
  3. Weiss LM, Kim K. The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci 2000;; 5: D391–D405.[CrossRef]
    [Google Scholar]
  4. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989;; 27: 1787–1792.
    [Google Scholar]
  5. Nicoll S, Burns SM, Brettle RP, Leen CSL. A comparison of two methods of gene amplification for the diagnosis of Toxoplasma gondii in AIDS. J Infect 1996;; 33: 177–183.[CrossRef]
    [Google Scholar]
  6. Cazenave J, Cheyrou A, Blouin P, Johnson AM, Begueret J. Use of polymerase chain reaction to detect Toxoplasma. J Clin Pathol 1991;; 44: 1037.
    [Google Scholar]
  7. Bohne W, Parmley SF, Young S, Gross U. In: Gross U (ed) Toxoplasma gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996:; 81–91.
  8. Franzen C, Altfeld M, Hegener P.et al. Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients. J Clin Microbiol 1997;; 35: 2639–2641.
    [Google Scholar]
  9. Novati R, Castagna A, Morsica G.et al. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994;; 8: 1691–1694.[CrossRef]
    [Google Scholar]
  10. Pelloux H, Dupouy-Camet, J, Derouin F, Aboulker J-P, Raffi Fand the Bio-Toxo Study Group. A multicentre prospective study for the polymerase chain reaction detection of Toxoplasma gondii DNA in blood samples from 186 AIDS patients with suspected toxoplasmic encephalitis. AIDS 1997;; 11: 1888–1890.[CrossRef]
    [Google Scholar]
  11. Verhofstede C, Reniers S, Colebunders R, van Wanzeele F, Plum J. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS 1993;; 7: 1539–1541.
    [Google Scholar]
  12. Bohne W, Gross U, Ferguson DJP, Heeseman J. Cloning and characterisation of a bradyzoite-specifically expressed gene (hsp30/bag 1) of Toxoplasma gondii related to genes encoding small heat-shock proteins of plants. Mol Microbiol 1995;; 16: 1221–1230.[CrossRef]
    [Google Scholar]
  13. Soëte M, Dubremetz JF. Toxoplama gondii: kinetics of stage-specific protein expression during tachyzoite-bradyzoite conversion in vitro. In: Gross U (ed) Toxoplasma gondii. (Current Topics in Microbiology and Immunology, vol 219) Berlin, Springer-Verlag. 1996:; 75–80.
  14. Parmley SF, Yang S, Harth G, Sibley D, Sucharzuk A, Remington JS. Molecular characterization of a 65-kilodaldon Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol Biochem Parasitol 1994;; 66: 283–296.[CrossRef]
    [Google Scholar]
  15. Lane A, Soete M, Dubremetz JF, Smith JE. Toxoplasma gondii: appearance of specific markers during the development of tissue cysts in vitro. Parasitol Res 1996;; 82: 340–346.[CrossRef]
    [Google Scholar]
  16. Savva D, Morris JC, Johnson JD, Holliman RE. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol 1990;; 32: 25–31.[CrossRef]
    [Google Scholar]
  17. Schoondermark van de Ven E, Galama J, Kraaijeveld C, van Druten J, Mewissen J, Melchers W. Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993;; 16: 661–666.[CrossRef]
    [Google Scholar]
  18. Soëte M, Fortier B, Camus D, Dubremetz JF. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp Parasitol 1994;; 76: 259–264.
    [Google Scholar]
  19. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989;; 339: 237–238.[CrossRef]
    [Google Scholar]
  20. Contini C, Seraceni S, Cultrera R. Different PCR systems to detect Toxoplasma gondii tachyzoites or bradyzoites in clinical specimens from patients with and without overt disease. J Eukaryot Microbiol 1999;; 46: 77S–78S.[CrossRef]
    [Google Scholar]
  21. Khalifa KES, Roth A, Roth B, Arastah KN, Janischichke K. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994;; 32: 2813–2819.
    [Google Scholar]
  22. Odberg-Ferragut C, Soete M, Engels A.et al. Molecular cloning of the Toxoplasma gondii sag-4 gene encoding an 18 kDA bradyzoite specific surface protein. Mol Biochem Parasitol 1996;; 82: 237–244.[CrossRef]
    [Google Scholar]
  23. Cultrera R, Seraceni S, Contini C. Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens. Mol Cell Probes 2002;; 16: 31–39.[CrossRef]
    [Google Scholar]
  24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual vol. 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press. 1989:; 9.449.44.
  25. Dembo A, Karlin S, Zeitouni O. Limit distribution of maximal non-aligned two-sequence segmental score. Ann Prob 1994;; 22: 2022–2039.[CrossRef]
    [Google Scholar]
  26. Karlin S, Altschul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci USA 1990;; 87: 2264–2268.[CrossRef]
    [Google Scholar]
  27. Lunde MN, Jacobs L. Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol 1983;; 69: 806–808.[CrossRef]
    [Google Scholar]
  28. Weiss LM, La Place D, Tanowitz HB, Wittner M. Identification of Toxoplasma gondii bradyzoite-specific monoclonal antibodies. J Infect Dis 1992;; 166: 213–215.[CrossRef]
    [Google Scholar]
  29. Ammassarri A, Murri R, Cingolani A, De Luca A, Antinori A. AIDS-associated cerebral toxoplamosis: an update on diagnosis and treatment. In: Gross U (ed) Toxoplasma gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996:; 209–222.
  30. Cristina N, Liaud M-F, Santoro F, Oury B, Ambrose-Thomas P. A family of repeated DNA sequences in Toxoplasma gondii: cloning, sequence analysis, and use in strain characterization. Exp Parasitol 1991;; 73: 73–81.[CrossRef]
    [Google Scholar]
  31. Roth A, Roth B, Hoffken G, Steuber S, Khalifa KI, Janitschke K. Application of polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1992;; 11: 1177–1181.[CrossRef]
    [Google Scholar]
  32. Khoury H, Adkins D, Brown R.et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999;; 23: 409–411.[CrossRef]
    [Google Scholar]
  33. Lamoril J, Molina JM, de Gouvello A.et al. Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J Clin Pathol 1996;; 49: 89–92.[CrossRef]
    [Google Scholar]
  34. Cingolani A, De Luca A, Ammassari A.et al. Detection of T. gondii-DNA by PCR in AIDS-related toxoplasmic encephalitis. J Eukaryot Microbiol 1996;; 43: 118S–119S.[CrossRef]
    [Google Scholar]
  35. Odaert H, Soête M, Fortier B, Camus D, Dubremetz JF. Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression. Parasitol Res 1996;; 82: 28–31.[CrossRef]
    [Google Scholar]
  36. Gross U, Bohne W, Soëte M, Dubremetz JF. Developmental differentiation between tachyzoites and bradyzoites of Toxoplasma gondii. Parasitol Today 1996;; 12: 30–33.[CrossRef]
    [Google Scholar]
  37. Gross U, Bohne W, Luder CGK.et al. Regulation of developmental differentiation in the protozoan parasite Toxoplasma gondii. J Eukaryot Microbiol 1996;; 43: 114S–116S.[CrossRef]
    [Google Scholar]
  38. Eggers C, Gross U, Klinker H, Schalke B, Stellbrink HJ, Kunze K. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol 1995;; 242: 644–649.[CrossRef]
    [Google Scholar]
  39. Dupoy-Camet J, Lavareda de Souza S.et al. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol 1993;; 31: 1866–1869.
    [Google Scholar]
  40. Foudrinier F, Aubert D, Puygauthier-Tobas D.et al. Detection of Toxoplasma gondii in immunodeficient subjects by gene amplification: influence of therapeutics. Scand J Infect Dis 1996;; 28: 383–386.[CrossRef]
    [Google Scholar]
  41. Araujo FG, Huskinson J, Remington JS. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother 1991;; 35: 293–299.[CrossRef]
    [Google Scholar]
  42. Gross U, Pohl F. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. In: Gross U (ed) Toxoplasma gondii. (Current Topics in Microbiology and Immunology, vol. 219) Berlin, Springer-Verlag. 1996:; 235–245.
  43. Pomeroy C, Kline S, Jordan MC, Filice GA. Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: antimicrobial activity of macrophages. J Infect Dis 1989;; 160: 305–311.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/0022-1317-51-10-879
Loading
/content/journal/jmm/10.1099/0022-1317-51-10-879
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error